Press Releases

Please select from the following for recent news and information about Torax Medical.

January 13, 2012

TORAX MEDICAL'S LINX® REFLUX MANAGEMENT SYSTEM RECEIVES UNANIMOUS RECOMMENDATION FROM FDA ADVISORY PANEL
November 14, 2011

TORAX MEDICAL RECEIVES CE MARK FOR THE FENIX CONTINENCE RESTORATION SYSTEM
November 10, 2011

FIRST SCOTTISH PATIENT RECEIVES BRAND NEW TREATMENT
April 7, 2010

TORAX MEDICAL RECEIVES CE MARK FOR IT'S LINX® ANTI-REFLUX TREATMENT
June 28, 2005

TORAX MEDICAL, INC. COMPLETES $10 MILLION SERIES B FINANCING

January 13, 2012

TORAX MEDICAL'S LINX® REFLUX MANAGEMENT SYSTEM RECEIVES UNANIMOUS RECOMMENDATION FROM FDA ADVISORY PANEL
November 14, 2011

TORAX MEDICAL RECEIVES CE MARK FOR THE FENIX CONTINENCE RESTORATION SYSTEM
November 10, 2011

FIRST SCOTTISH PATIENT RECEIVES BRAND NEW TREATMENT
April 27, 2011

NEW CUTTING EDGE PROCEDURE COULD FILL TREATMENT GAP IN GORD
April 27, 2011

NEW CUTTING EDGE PROCEDURE BRINGS FRESH HOPE TO ACID REFLUX SUFFERERS
April 7, 2010

TORAX MEDICAL RECEIVES CE MARK FOR IT'S LINX® ANTI-REFLUX TREATMENT
June 28, 2005

TORAX MEDICAL, INC. COMPLETES $10 MILLION SERIES B FINANCING

CAUTION - Torax's LINX® Reflux Management System and FENIX™ Continence Restoration System are INVESTIGATIONAL DEVICES,
LIMITED BY U.S. FEDERAL LAW TO INVESTIGATIONAL USE. Not available for sale in the United States.

The LINX® Reflux Management System has received European CE Mark approval for treatment
of Gastro-oesophageal Reflux Disease (GORD), also known as GERD, and is available for sale in Europe.

The FENIX™ Continence Restoration System has received European CE Mark approval for treatment of Fecal Incontinence (FI) and is available for sale in Europe.
Torax® Medical, LINX® Reflux Management System and FENIX™ Continence Restoration System are trademarks of Torax® Medical, Inc.
© 2011 Torax® Medical, Inc. All rights reserved.

Your Location:

Press Releases

January 13, 2012

November 14, 2011

November 10, 2011

April 7, 2010

June 28, 2005